GRCE
Grace Therapeutics, Inc.
-0.01 (-0.23%)2.14USD31.7K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 697K | 420K | 462K | 568K | 955K | 2.2M | 3.0M | 2.7M | 1.7M | 1.4M | 460K | 1.1M |
| 銷售管理費用 | 1.7M | 2.6M | 2.0M | 2.0M | 2.1M | 1.5M | 1.9M | 2.3M | 1.6M | 1.6M | 1.6M | 1.9M |
| 營業利益 | −15.9M+415% | −3.0M-19% | −2.4M-49% | −2.5M-49% | −3.1M-5% | −3.7M+22% | −4.8M+131% | −5.0M+11% | −3.3M | −3.0M | −2.1M | −4.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −15.8M+370% | −1.2M-72% | −2.3M-33% | −938K-64% | −3.4M+6% | −4.2M+74% | −3.4M+5% | −2.6M-35% | −3.2M | −2.4M | −3.3M | −4.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.91+333% | -0.06-83% | -0.14-53% | -0.06-75% | -0.21+24% | -0.36+71% | -0.30-30% | -0.24-56% | -0.17 | -0.21 | -0.43 | -0.54 |
| 稀釋股數 | 17.3M | 16.5M | 16.9M | 15.9M | 15.9M | 11.5M | 11.5M | 10.9M | 9.5M | 11.5M | 7.6M | 7.4M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 13.8M | 17.0M | 18.7M | 16.9M | 20.0M | 11.1M | 15.2M | 19.4M | 23.0M | 18.5M | 27.0M | 21.6M |
| 應收帳款 | – | – | – | – | – | – | – | 398K | 722K | 959K | 837K | 837K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 50.1M | 66.7M | 68.5M | 66.6M | 69.8M | 61.2M | 65.3M | 69.7M | 73.3M | 76.2M | 78.2M | 73.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.9M | 2.8M | 3.6M | 3.8M | 6.3M | 9.1M | 9.2M | 10.4M | 11.6M | 11.5M | 11.5M | 9.0M |
| 股東權益 | 48.2M | 63.9M | 64.9M | 62.8M | 63.6M | 52.1M | 56.1M | 59.4M | 61.7M | 64.7M | 66.7M | 64.0M |
| 負債比 | 3.7% | 4.1% | 5.3% | 5.6% | 9.0% | 14.8% | 14.1% | 14.9% | 15.8% | 15.1% | 14.7% | 12.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −3.2M+79% | – | – | – | −1.8M | – | – | −3.6M-42% | – | – | – | −6.2M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −7.8M | –% | -0.47 | – |
| FY2025 | – | – | −9.6M | –% | -0.79 | – |
| FY2024 | – | – | −12.9M | –% | -1.35 | – |
| FY2023 | – | – | −42.4M | –% | -5.71 | – |
| FY2022 | 100M | +50920.4% | −9.8M | -9.8% | -0.27 | – |
| FY2021 | 196K | – | −19.7M | -10,039.8% | -1.33 | – |
| FY2020 | – | – | −25.5M | –% | -0.30 | – |
| FY2019 | – | – | −39.4M | –% | -0.73 | – |